Categories: BioTechBodyLearnMedtechPlatformScience
Neurocrine Biosciences is a neuroscience-focused, biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs, but few options. We are dedicated to discovering and developing life-changing treatments for patients with under-addressed neurological, endocrine and psychiatric disorders. The company’s diverse portfolio includes FDA-approved treatments for tardive dyskinesia, Parkinson’s disease, endometriosis* and uterine fibroids* , as well as clinical programs in multiple therapeutic areas. For three decades, we have applied our unique insight into neuroscience and the interconnections between brain and body systems to treat complex conditions. We relentlessly pursue medicines to ease the burden of debilitating diseases and disorders, because you deserve brave science.
*in collaboration with AbbVie
Location: United States, California, San Diego
Investors 1
Mentions in press and media 18
| Date | Title | Description | Source |
| 08.09.2021 | Neurocrine Biosciences : Xenon Pharmaceuticals Announces Col... | BURNABY, British Columbia, Sept. 08, 2021 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XEN... | marketscre... |
| 05.08.2021 | Neurocrine Biosciences Announces Completion of Enrollment in... | | prnewswire... |
| 03.08.2021 | Neurocrine Biosciences : Reports Second Quarter 2021 Financi... | SAN DIEGO, Aug. 3, 2021 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced ... | marketscre... |
| 19.07.2021 | Neurocrine Biosciences Announces Conference Call and Webcast... | | prnewswire... |
| 28.05.2021 | BB Biotech : investment trust review highlights long t... | Launched in 1993, BB Biotech (BION) is one of the largest specialist funds investing in the fast-gro... | marketscre... |
| 05.05.2021 | Neurocrine Biosciences : Reports First Quarter 2021 Financia... | SAN DIEGO, May 5, 2021 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced i... | marketscre... |
| 03.05.2021 | Neurocrine Biosciences Supports Mental Health Month and Tard... | | prnewswire... |
| 16.04.2021 | Neurocrine Biosciences Announces Appointment of Johanna Merc... | | prnewswire... |
| 14.04.2021 | Neurocrine Biosciences Announces Conference Call and Webcast... | | prnewswire... |
| 02.03.2021 | Neurocrine Biosciences Announces Top-Line Results from Phase... | | prnewswire... |
| 20.01.2021 | Neurocrine Biosciences Announces Conference Call and Webcast... | | prnewswire... |
| 19.11.2020 | Neurocrine Biosciences Announces Repurchase of Convertible N... | | prnewswire... |
| 06.10.2020 | Neurocrine Biosciences Announces Conference Call and Webcast... | | prnewswire... |
| 28.09.2020 | Neurocrine Biosciences to Present New Data Analyses of Once-... | | prnewswire... |
| 14.09.2020 | Neurocrine Biosciences Announces Once-Daily ONGENTYS® (opica... | | prnewswire... |
| 11.09.2020 | Neurocrine Biosciences Presents New Data Analyses Demonstrat... | | prnewswire... |
| 03.09.2020 | Neurocrine Biosciences to Present New Data from its Movement... | | prnewswire... |
| 11.11.2018 | Leadership winner, medium company — Kevin Gorman of Neurocri... | Neurocrine Biosciences has experienced a dramatic turnaround in recent years. The Carmel Valley-base... | sandiegoun... |
Show more
Reviews 0
